A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection - Concepedia

Concepedia

Publication | Open Access

A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis against<i>Pneumocystis carinii</i>Pneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

DOI Full Paper Access

205

Citations

35

References

2001

Year

Juan Carlos López Bernaldo de Quirós, José M. Miró, José M. Peña, Daniel Podzamczer, J. Alberdi, Estebán Martínez, Jaime Cosín, Xavier Claramonte, Juan González, Peré Domingo,

New England Journal of Medicine

Abstract

In HIV-infected patients receiving highly active antiretroviral therapy, primary and secondary prophylaxis against P. carinii pneumonia can be safely discontinued after the CD4 cell count has increased to 200 or more per cubic millimeter for more than three months.

References

	Year	Citations

Page 1